Two common blood pressure meds fare equally in preventing heart woes
Review shows no difference between atenolol, metoprolol in warding off heart attack or stroke.
(HealthDay)—In a review that compared two common heart drugs against each other, researchers found no difference between atenolol and metoprolol in terms of preventing stroke, heart attack or heart failure for patients with high blood pressure who were placed on the medications.
Atenolol (Tenormin) and metoprolol tartrate (Lopressor) are beta blockers that are widely used to treat high blood pressure and heart problems. Previous research has suggested that atenolol might be less effective than other high blood pressure drugs for preventing cardiovascular events in patients with high blood pressure.
In this study, researchers reviewed the medical records of nearly 121,000 U.S. patients with high blood pressure but no history of heart disease who started taking one of the two drugs between 2000 and 2009. Atenolol was used by about 10 times more patients than metoprolol.
During a follow-up averaging about five years, there was no statistically significant difference in rates of heart attack, stroke or heart failure between the two groups of patients.
"In conclusion, we found no differences in [heart] event rates ... with either atenolol or metoprolol," said review author Emily Parker, of HealthPartners Institute for Education and Research in Minneapolis, and colleagues. However, the researchers added that the findings "should be interpreted cautiously, since there have been no trials comparing these two beta blockers directly."
Two experts not connected to the study said patients have many options for treating high blood pressure.
"Like many of my colleagues, I also use beta blockers as an add-on antihypertensive strategy for those patients being treated for hypertension and not yet having other cardiac problems," said Dr. David Friedman, chief of heart failure services at North Shore-LIJ's Plainview Hospital, in Plainview, N.Y. He added, however, that "when it comes to treating blood pressure alone, beta blockers have taken a back seat to other medications such as diuretics."
Dr. Kenneth Ong is acting chair of the department of medicine and cardiology at The Brooklyn Hospital Center, in New York City. He noted that there has been debate as to whether atenolol works as well as other drugs used to fight high blood pressure.
"While the [new] study is a retrospective analysis, it suggests that there may be no merit to changing atenolol to metoprolol tartrate," he said. "It will be important to verify these findings with a randomized, prospective trial."
The review was funded by the U.S. National Heart, Lung and Blood Institute, and was published online Aug. 27 in the Archives of Internal Medicine.
More information: The U.S. National Heart, Lung, and Blood Institute has more about treatment of high blood pressure.
Journal reference:
JAMA Internal Medicine
Copyright © 2012 HealthDay. All rights reserved.
-
Blood pressure drugs don't protect against colorectal cancer
May 14, 2012 |
not rated yet |
0
-
Heart failure treated 'in the brain'
Mar 25, 2008 |
not rated yet |
0
-
Hypertension: Beta-blockers effective in combination therapies
Jan 19, 2010 |
not rated yet |
0
-
Take your blood pressure meds before bed
Oct 24, 2011 |
not rated yet |
0
-
FDA approves a new beta blocker
Dec 18, 2007 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Dipole term in multipole expansion
3 hours ago
-
Bubbles in a Pre-Boiling/Boiling pot of water
4 hours ago
-
Assumptions of Griffith's fracture theory
15 hours ago
-
Current leading voltage or vice versa concept
16 hours ago
-
Angular Frequency of AC voltage
19 hours ago
-
Modeling Rigid Body - Unsure about Euler angles and angular velocity
20 hours ago
- More from Physics Forums - Classical Physics
More news stories
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
11 minutes ago |
not rated yet |
0
Post-approval TAVI registry shows high rates of device success at one year
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...
Cardiology
22 minutes ago |
not rated yet |
0
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Cardiology
1 hour ago |
not rated yet |
0
|
Study identifies superior hypertension treatment, efficacy between sexes
(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to ...
Cardiology
9 hours ago |
5 / 5 (1) |
0
Evaluating a new way to open clogged arteries
Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...
Cardiology
10 hours ago |
4.8 / 5 (4) |
0
|
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Researchers find genetic risk factor for pulmonary fibrosis
A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...
Biomarkers discovered for inflammatory bowel disease
Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...
Changing cancer's environment to halt its spread
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...
Global recommendations on child medicine
Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...
Novel RNA-based classification system for colorectal cancer
A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...
Aug 28, 2012
Rank: not rated yet
Perhaps neither drug had any effect at all.